 |
Sacrosidase |
|---|---|
| Trade Name | Sucraid |
| Orphan Indication | Congenital Sucrase-Isomaltase Deficiency |
| USA Market Approval | USA |
| USA Designation Date | 1993-12-10 00:00:00 |
| Sponsor | QOL Medical, LLC;4445 North Highway, A1A, 241;Vero Beach, Florida, 32963 |
Related Access Program